PubMed · 2006 · 18 citations · 0 references
MedicineOncologyPathologyMolecular OncologyNeoplasiaTumor ProgressionAngiogenesisAngiogenesis In CancerCancer BiomarkersCancer Molecular PathologyCancer ProgressionMalignant NeoplasmsAngiogenic BiomarkersPrimary Tumor CharacterizationPrognostic Factors AnalysisTyrosine Kinase ReceptorsVascular Endothelial Growth FactorVascular Endothelial Growth Factor Receptor SignalingVascular Endothelial Growth Factor ReceptorsVascular Endothelial Growth Factor Signaling
BACKGROUND & OBJECTIVE: Vascular endothelial growth factor (VEGF) and its receptors fms-like tyrosine kinase-1 (Flt-1) and kinase insert domain containing receptor (KDR) play critical roles in angiogenesis and tumor progression. This study was to explore the correlations of VEGF, Flt-1 and KDR expression to clinical features and prognosis of nasopharyngeal carcinoma (NPC) patients. METHODS: Immunohistochemistry was adopted to detect the expression of VEGF, Flt-1, and KDR in 127 specimens of NPC. SPSS statistical software was used to analyze their correlations to clinical features and prognosis of NPC patients. RESULTS: The positive rates of VEGF,Flt-1,and KDR were 66.9%, 90.6%, and 88.2% in the NPC specimens. The expression of VEGF was positively related to the expression of Flt-1 and KDR (r=0.292, P<0.01; r=0.287, P<0.01). The expression of Flt-1 was positively related to the expression of KDR (r=0.723, P<0.01). VEGF expression was related to primary tumor site, lymph node metastasis, and clinical stage (P=0.04, P<0.01, P=0.02, respectively); KDR expression was related to primary tumor site (P=0.03); all of them were related to local recurrence and/or distal metastasis (P<0.01, P<0.01, P=0.01, respectively), and poor overall survival (P<0.01, P=0.01, P=0.03, respectively). Cox multivariate analysis showed age of more than 50 years and positive VEGF expression were independent prognostic factors (P<0.01, P<0.01). CONCLUSION: VEGF, Flt-1, and KDR are widely expressed in NPC tissues, and are positively related to clinical features and prognosis of NPC patients.